Nabriva Therapeutics plc Quarterly Quick Ratio in % from Q2 2020 to Q1 2023

Taxonomy & unit: ratio: %
Description: The acid-test ratio, also called the quick ratio, is a metric used to see if a company is positioned to sell assets within 90 days to meet immediate expenses.
Summary: Nabriva Therapeutics plc quarterly Quick Ratio history and growth rate from Q2 2020 to Q1 2023.
Nabriva Therapeutics plc Quick Ratio for the quarter ending March 31, 2023 was 53.4 %, a 25.8% decline year-over-year.

Quick Ratio, Quarterly (%)

Quick Ratio, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q1 2023	53.4	-18.6	-25.8%	Mar 31, 2023
Q4 2022	68.6	+6.77	+11%	Dec 31, 2022
Q3 2022	79.2	+25.7	+48.1%	Sep 30, 2022
Q2 2022	78.9	+33	+72.1%	Jun 30, 2022
Q1 2022	72	+28.1	+64.1%	Mar 31, 2022
Q4 2021	61.8	+21.7	+54%	Dec 31, 2021
Q3 2021	53.5	+22	+70%	Sep 30, 2021
Q2 2021	45.8	+27	+143%	Jun 30, 2021
Q1 2021	43.9			Mar 31, 2021
Q4 2020	40.1			Dec 31, 2020
Q3 2020	31.5			Sep 30, 2020
Q2 2020	18.8			Jun 30, 2020

Showing 1 to 12 of 12 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.